DNA elements recognizing NF-Y and Sp1 regulate the human multidrug- resistance gene promoter

Molecular Pharmacology

Volumn 51, Issue 6, 1997, Pages 963-971

  Sundseth, Rebecca ^a,d   MacDonald, Gene ^b   Ting, Jenny ^b   King, A Christie ^a,c  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Shire Canada   (Canada)

^d AndCare   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; NUCLEAR FACTOR; TRANSCRIPTION FACTOR SP1;

ARTICLE; CANCER RESISTANCE; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN DOMAIN; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

EID: 0030922309     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.6.963     Document Type: Article

References (39)

1. Fojo, A. T., K. Ueda, D. J. Slamon, D. G. Poplack, M. M. Gottesman, and I. Pastan. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. USA 84:265-269 (1987).
2. Kohno, K., S. Sato, T. Uchiumi, H. Takano, S. Kato, and M. Kuwano. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene. J. Biol. Chem. 265:19690-19696 (1990).
3. Burt, R. K., S. Garfield, K. Johnson, and S. S. Thorgeirsson. Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 9:2329-2332 (1988).
4. Chin, K.-V., K. Ueda, I. Pastan, and M. M. Gottesman. Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science (Washington D. C.) 255:459-462 (1992).
5. Harris, A. L., and D. Hochhauser. Mechanisms of multidrug resistance in cancer treatment. Acta Oncol. 31:205-213 (1992).
6. Chan, H. S., G. Haddad, P. S. Thorner, G. DeBoer, Y. P. Lin, N. Ondrusek, H. Yeger, and V. Ling. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med. 325:1608-1614 (1991).
7. Chin, K.-V., S. Tanaka, G. Darlington, I. Pastan, and M. M. Gottesman. Heat shock and arsenite increase expression of the multidrug resistance (mdr1) gene in human renal carcinoma cells. J. Biol. Chem. 265:221-226 (1990).
8. Fairchild, C. R., S. P. Ivy, T. Rushmore, G. Lee, P. Koo, M. E. Goldsmith, C. E. Myers, E. Farber, and K. H. Cowan. Carcinogen-induced mdr over-expression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 84:7701-7705 (1987).
9. Kioka, N., Y. Yamano, T. Komano, and K. Ueda. Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett. 301:37-40 (1992).
10. Kohno, K., S. Sato, H. Takano, K. Matsuo, and M. Kuwano. The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem. Biophys. Res. Commun. 165:1415-1421 (1989).
11. Miyazaki, M., K. Kohno, T. Uchiumi, H. Tanimura, K. Matsuo, M. Nasu, and M. Kuwano. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem. Biophys. Res. Commun. 187:677-684 (1992).
12. Uchiumi, T., K. Kohno, H. Tanimura, K. Matsuo, S. Sato, Y. Uchida, and M. Kuwano. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Diff. 4:147-157 (1993).
13. Madden, M. J., C. S. Morrow, M. Nakagawa, M. E. Goldsmith, C. R. Fairchild, and K. H. Cowan. Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human mdr1 gene in vivo. J. Biol. Chem. 268:8290-8297 (1993).
14. Ueda, K., I. Pastan, and M. M. Gottesman. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene. J. Biol. Chem. 262:17432-17436 (1987).
15. Cornwell, M. M. The human multidrug resistance gene: sequences upstream and downstream of the initiation site influence transcription. Cell Growth Diff. 1:607-615 (1990).
16. Cornwell, M. M., and D. E. Smith. Sp1 activates the MDR1 promoter through one of two distinct G-rich regions that modulate promoter activity. J. Biol. Chem. 268:19505-19511 (1993).
17. McCoy, C., D. E. Smith, and M. M. Cornwell. 12-O-Tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol Cell. Biol. 15:6100-6108 (1995).
18. Goldsmith, M. E., M. J. Madden, C. S. Morrow, and K. H. Cowan. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J. Biol. Chem. 268:5856-5860 (1993).
19. Yu, L., Q. Wu, C.-P. Huang Yang, and S. Band Horwitz. Coordination of transcription factors, NF-Y and C/EBPB, in the regulation of the mdr1b promoter. Cell Growth Diff. 6:1505-1511 (1995).
20. Ogura, M., T. Takatori, and T. Tsuruo. Purification and characterization of NF-R1 that regulates the expression of the human multidrug resistance (MDR1) gene. Nucleic Acids Res. 20:5811-5817 (1992).
21. Swick, A. G., M. C. Blake, J. W. Kahn, and J. C. Azizkhan. Functional analysis of GC element binding and transcription in the hamster dihydrofolate reductase gene promoter. Nucleic Acids Res. 17:9291-9304 (1989).
22. MacDonald, G. H., Y. Itoh-Lindstrom, and J. P.-Y. Ting. The transcriptional regulatory protein YB-1, promotes single-stranded region in the DRα promoter. J. Biol. Chem. 270:3527-3533 (1995).
23. Noonan, K. E., C. Beck, T. A. Holzmayer, J. E. Chin, J. S. Wunder, I. L. Andrulis, A. F. Gazdar, C. L. Willman, B. Griffith, D. D. Von Hoff, and I. B. Roninson. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:7160-7164 (1990).
24. Smale, S. T., and D. Baltimore. The "initiator" as a transcription control element. Cell. 57:103-113 (1989).
25. Ueda, K., D. P. Clark, C. Chen, I. B. Roninson, M. M. Gottesman, and I. Pastan. The human multidrug resistance (mdr1) gene. J. Biol. Chem. 262:505-508 (1987).
26. Faisst, S., and S. Meyer. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20:3-26 (1992).
27. Wright, K. L., T. L. Moore, B. J. Vilen, A. M. Brown, and J. P.-Y. Ting. Major histocompatibility complex class II-associated invariant chain is up-regulated by cooperative interactions of Sp1 and NF-Y. J. Biol. Chem. 270:20978-20986 (1995).
28. Zeleznik-Le, N. J., J. C. Azizkhan, and J. P.-Y. Ting. Affinity-purified CCAAT-box-binding protein (YEBP) functionally regulates expression of a human class II major histocompatibility complex gene and the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA 88:1873-1877 (1991).
29. Sherman, P. A., P. V. Basta, T. L. Moore, A. M. Brown, and J. P.-Y. Ting. Class II box consensus sequences in the HLA-DRα gene: transcriptional function and interaction with nuclear factors. Mol. Cell. Biol. 9:50-56 (1989).
30. Chodosh, L. A., A. S. Baldwin, R. W. Carthew, and P. A. Sharp. Human CCAAT-binding proteins have heterologous subunits. Cell 53:11-24 (1988).
31. Bucher, P. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212:563-578 (1990).
32. Dorn, A., J. Bollekens, A. Staub, C. Benoist, and D. Mathis. A multiplicity of CCAAT box-binding proteins. Cell. 50:863-872 (1987).
33. Asakuno, K., K. Kohno, T. Uchiumi, T. Kubo, S. Sato, M. Isono, and M. Kuwano. Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. Biochem. Biophys. Res. Commun. 199:1428-1435 (1994).
34. Rauscher, F. J., III, J. F. Morris, O. E. Tournay, D. M. Cook, and T. Curran. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science (Washington D. C.) 250:1259-1262 (1990).
35. Cao, X., R. Mahendran, G. R. Guy, and Y. H. Tan. Detection and characterization of cellular EGR-1 binding to its recognition site. J. Biol. Chem. 268:16949-16957 (1993).
36. Danilition, S. L., R. M. Frederickson, C. Y. Taylor, and N. G. Miyamoto. Transcription factor binding and spacing constraints in the human beta-actin proximal promoter. Nucleic Acids Res. 19:6913-6922 (1991).
37. Milos, P. M., and K. S. Zaret. A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. Genes Dev. 6:991-1004 (1992).
38. Hooft van Huijsduijnen, R., X. Y. Li, D. Black, H. Matthes, C. Benoist, and D. Mathis. Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J. 9:3119-3127 (1990).
39. Spitkovsky, D. D., B. Royer-Pokora, H. Delius, F. Kisseljov, N. A. Jenkins, D. J. Gilbert, N. G. Copeland, and H.-D. Royer. Tissue restricted expression and chromosomal localization of the YB-1 gene encoding a 42 kD nuclear CCAAT bindine Drotein. Nucleic Acids Res. 20:797-803 (1992).